Anthropic's president says market incentives alone would not have produced its 100-country medical AI rollout
Anthropic and OpenEvidence are giving doctors in about 100 low- and middle-income countries free access to a clinical search tool that is already free in the US and Europe, where physicians ran 42 million queries in August.
The Investor · Invest desk
What happened
- Anthropic and OpenEvidence are launching free clinical search for healthcare providers in around 100 countries, among them Angola, Haiti, Mongolia, Sudan and Uganda, on a country list OpenEvidence supplied to Reuters.
- Anthropic is providing the underlying models and OpenEvidence is adapting them to local medicine, for physicians who lack easy access to medical journals, specialists and continuing education.
- Founder Daniel Nadler estimated that several hundred million Americans will have been treated in 2026 by doctors who used the platform.
- The Wall Street Journal reported in August that Anthropic believes its healthcare and biology work will improve public sentiment about AI, one of the strategies it has shared with potential investors as it prepares to go public.
Why it matters
- What it costs cost The query cost sits with the two companies for a user base that pays nothing on either side of the income divide, so the program runs for as long as someone keeps paying for the compute.
- What's now possible capability Anthropic gets its models into clinical question-answering across about 100 countries without hiring a sales force in any of them, and what it pays for that is inference.
- Who's exposed exposure If the regional adaptation work falls short, the visible failure is a treatment answer given to a patient in Sudan or Mongolia, and it attaches to Anthropic's models while healthcare is part of its pitch to investors.
- What doesn't add up contradiction The country count is the company's own, and one of the two published accounts calls the rollout dozens of countries in one line and around 100 in another. Nobody outside the companies has counted.
Next story · Invest · yesterday
At $2 trillion, Anthropic would list at about 30 times its latest quarter annualizedConfirmed23 publishers
Anthropic supplies the models and OpenEvidence adapts them to local medicine [1]. Inference is the recurring cost of that split, and it rises with use. In the US, doctors ran 42 million queries through OpenEvidence in August alone, founder Daniel Nadler told Reuters [11], which works out at about 1.35 million a day [15]. Neither published account says what the new program costs or who pays for the compute [14].
OpenEvidence has been free to clinicians in the US and Europe for some time [5], and the specialized version for low- and middle-income countries is free as well [3]. The change is where it is offered. Anthropic president Daniela Amodei told Reuters that the technology had become capable enough for the initiative but that "market incentives by themselves would not cause it to happen" without a philanthropic push [7]. An officer of the company is saying the usage does not pay for itself.
Last week Anthropic built a lab for physical biology work aimed at drug development [9]. What it gets back for the clinical giveaway is sentiment, and it has already put that argument in front of investors [10].
Checking the distribution case is harder. More than a million queries a day inside clinical workflow is a position of some value, and PYMNTS Intelligence has found that AI adoption in healthcare is not as extensive as in sectors such as financial services [20], so getting in early on how doctors look things up may be worth money later.
The first thing that can go wrong is clinical. Reuters reported the criticism that systems trained primarily on data from wealthier countries may not align with "local practice conditions" [16]. "One hundred percent of what we are developing for these areas is designed to be context adaptive," Nadler said [18], and the company worked with healthcare organizations in Rwanda and Botswana earlier this year to adapt its tools [12]. Delivery is a separate constraint: Nadler said most doctors still have smartphones even where clinics have inconsistent power [19]. Ahmed Bendary, a cardiologist at Benha University in Egypt, told Reuters that the expansion is especially important for doctors in places where access to medical research is limited [13].
I think the philanthropic reading is right, because Anthropic's president gave it on the record and dated it to a push that market pricing would not have funded [7]. The counter-thesis is that free access across about 100 countries is a cheap way into clinical care, and that a platform absorbing 42 million US queries a month will charge somebody for them eventually [3][11]. Two developments would settle it against the first reading: a paid tier in any of the new markets, or a renewal of the program that needs no philanthropic money.
What to watch
- Whether any Anthropic listing disclosure puts a number on the donated compute and names the philanthropic funder behind the free access.
- Whether an independent count of participating countries and physicians appears, against the list OpenEvidence provided to Reuters.
- Whether the Rwanda and Botswana adaptation work produces documented changes to the guidance the tool gives in low-resource clinics.
Information, not investment advice. This story is general information about companies and markets, drawn from cited reporting. It is not a recommendation to buy, sell or hold any security; check the cited sources before acting.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence48
- Adoption45
- Hype gap+25
- Incentives78
- Confidence55
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Anthropic and OpenEvidence are giving doctors in about 100 low- and middle-income countries free access to a clinical AI search tool, with Anthropic providing the models and OpenEvidence adapting them to local medicine; the rollout is aimed at physicians in places such as Uganda, Sudan and Haiti who lack easy access to medical journals and specialists.
- [2]
The companies told Reuters on Tuesday, Sept. 22, that the collaboration is designed to bring AI-driven clinical decisioning help to doctors in places that cannot access the technology.
- [3]
The program is being launched in around 100 countries, including Angola, Haiti, Mongolia, Sudan and Uganda, Reuters said, citing a list provided by OpenEvidence; the specialized version is open to healthcare providers for free in those countries.
- [4]
PYMNTS, citing Reuters, describes the initiative as free in "dozens of low and middle-income countries" and also says the program is being launched in around 100 countries, citing a list provided by OpenEvidence.
- [5]
The OpenEvidence platform is free to clinicians in the U.S. and Europe, and answers physicians' queries using information from peer-reviewed medical research and treatment guidelines.
- [6]
OpenEvidence founder and CEO Daniel Nadler stated that the platform uses multiple sources such as the New England Journal of Medicine and the NCCN guidelines in its responses.
- [7]
Anthropic President Daniela Amodei said the project would probably not have happened via normal market incentives alone, telling Reuters that the technology has become capable enough for the initiative but that "market incentives by themselves would not cause it to happen" without a philanthropic push.
- [8]
"Access to medical knowledge shouldn't depend on geography," OpenEvidence founder Daniel Nadler said.
- [9]
Reuters reported last week that Anthropic had constructed a lab to perform physical biology work focused on using AI for drug development.
- [10]
The Wall Street Journal reported in August that Anthropic believes its healthcare and biology-focused AI efforts will boost public sentiment about the technology, and that this is one of the strategies Anthropic has shared with potential investors as it prepares to go public.
- [11]
In the US, doctors made 42 million queries through OpenEvidence in August alone, Nadler told Reuters.
- [12]
Earlier this year, OpenEvidence worked with healthcare organizations in Rwanda and Botswana to adapt its tools.
- [13]
Dr. Ahmed Bendary, a cardiologist at Benha University in Egypt, told Reuters that the expansion is especially important for doctors in places where access to medical research is limited.
- [14]
Neither published account states what the program costs or who funds the compute behind the free access.
- [15]
42 million US queries in August is about 1.35 million queries a day.
- [16]
Critics warn that systems trained primarily on data from wealthier countries may not align with "local practice conditions", Reuters said.
- [17]
Nadler estimated that several hundred million Americans will have been treated in 2026 by doctors who used the medical platform.
- [18]
"One hundred percent of what we are developing for these areas is designed to be context adaptive," Nadler said.
- [19]
Unreliable electricity is a major challenge in many of the targeted low-resource settings, and Nadler said most of the doctors still have access to smartphones even when clinics have power inconsistencies.
- [20]
Research by PYMNTS Intelligence has shown that AI adoption in the healthcare field is not as extensive as in sectors like financial services.
Sources
2 independent publishers whose own reporting we read for this story.
- cryptopolitan.comAnthropic partners with OpenEvidence to bring medical AI to 100 countries
1 article · September 23, 2026
- pymnts.comAnthropic and OpenEvidence Team to Expand Reach of Medical AI
2 articles · September 23, 2026
Topics and entities
Topics
- Healthcare AI Adoption
- Clinical decision support
- AI lab IPO preparation
- Global Health Access